Xscribe-6AA-Afaxb
Xscribe-6AA-Afaxb is a cardiac stress exercise monitoring system (FDA Class II; FDA product code DPS, Electrocardiograph) made by Mortara Instrument, Inc., cleared under FDA 510(k) K152944 on 6 Jan 2016 (1 earlier submission) and listed in FDA GUDID since 13 Sep 2017 (UDI-DI 00817655021997), active as of 22 Oct 2026. 5 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
4 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00817655021997 | Date13 Sep 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK152944 | Date6 Jan 2016 | StatusActive |
Official records
- AccessGUDID record 00817655021997
- FDA 510(k) database K152944
- FDA 510(k) database K022618
From the FDA record
- Device description
- Cardiac Stress Testing System
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K152944 decided 6 Jan 2016 Active
- FDA GUDID UDI-DI 00817655021997 listed 13 Sep 2017 Listed
Recalls
-
- Ongoing Z-0321-2025
- Ongoing Z-0325-2025
There is the potential for exam files being assigned duplicate Unique Identifiers (UIDs),. If the system receiving the DICOM file (e.g., Picture Archiving and Communication System (PACS)) relies solely on the UID to accept exams, this could lead to a mismatch of the patients identification with their physiological data.
-
- Ongoing Z-0706-2024
- Ongoing Z-0705-2024
Potential distortion identified in electrocardiogram (ECG) readings when the Source Consistency Filter (SCF) is enabled.
-
- Terminated Z-1817-2020
Impacted Welch Allyn products may not meet the Defibrillation Withstand requirements of EN/IEC 60601-2-25 Medical Electrical Equipment.
Timeline
- Cleared FDA 510(k) K022618
- Cleared FDA 510(k) K152944
- Listed FDA GUDID 00817655021997
- Recall initiated FDA recalls Z-1817-2020
- Recall initiated FDA recalls Z-0706-2024
- Recall initiated FDA recalls Z-0705-2024
- Recall initiated FDA recalls Z-0321-2025
- Recall initiated FDA recalls Z-0325-2025
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- XScribe
- Generic name
- Cardiac stress exercise monitoring system
- Model / reference
- XSCRIBE-6AA-AFAXB
- Primary DI / UDI-DI
- 00817655021997
- FDA product code
- DPS
- GMDN term
- Cardiac stress exercise monitoring system
- Device class
- Class II
- Regulation number
- 870.2340
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code DPS (Electrocardiograph).
- Universal SmartECG by Vectracor, Inc.
- Cardiac Workstation 7000 860441 by Philips Medizin Systeme Böblingen GmbH
- Welch Allyn, Inc. 901133 ELI380-AAX12 by Welch Allyn, Inc.
- Welch Allyn, Inc. 901130 ELI230-ABA-AAAAX by Welch Allyn, Inc.
- CRITIKON CENTRAL STATIN MONITOR by Critikon Company, LLC
- ATRIA 3100, ATRIA 6100 by Cardiac Science Corporation
- CARDIO MONITOR CENTER VISION; MODEL S-CV7-00 by SHL TELEMEDICINE INTERNATIONAL LTD.
- VICARDIO 12B by Energy-Lab Technologies GmbH
- PHILIPS PAGEWRITER TOUCH CARDIOGRAPH, MODEL M5000A SERIES by Philips Medical Systems
- ATHANS EKG STANDARDIZER by Advanced Medical Concepts, Inc.